Denver PWM’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$450K Hold
7,211
– – 0.15% 61
2026
Q2
$460K Buy
7,211
+811
+13% +$46.6K 0.15% 61
2026
Q1
$359K Sell
6,400
-500
-7% -$29.1K 0.12% 67
2025
Q4
$319K Hold
6,900
– – 0.11% 63
2025
Q3
$319K Hold
6,900
– – 0.1% 65
2025
Q2
$319K Buy
6,900
+750
+12% +$36.8K 0.1% 65
2025
Q1
$375K Buy
+6,150
New +$358K 0.14% 49

Other funds holding BMY

Denver PWM's BMY Position: Q3 2026 in Review

Denver PWM held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 7,211 shares worth $450K. The position accounts for 0.15% of the portfolio, ranked #61.

Denver PWM first reported a position in BMY in Q1 2025 and has held it in 7 quarters since. The position peaked at $460K in Q2 2026. 1,530 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Denver PWM held 7,211 shares of Bristol-Myers Squibb worth $450K as of Q3 2026.
  • Denver PWM left its Bristol-Myers Squibb share count unchanged in Q3 2026.
  • Bristol-Myers Squibb made up 0.15% of Denver PWM's portfolio in Q3 2026, its #61 holding.
  • Denver PWM first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 7 quarters since.
  • Denver PWM's Bristol-Myers Squibb position peaked at $460K in Q2 2026.
  • 1,530 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Denver PWM's 13F filing for Q3 2026, filed 22 Oct 2026.